ST
IONS icon

Spot Trading’s Ionis Pharmaceuticals IONS Stock Holding History

Spot Trading’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$598K Buy
11,800
+900
+8% +$47.1K 0.01% 1513
2017
Q2 		$554K Sell
10,900
-6,600
-38% -$307K 0.01% 1519
2017
Q1 		$704K Buy
17,500
+4,200
+32% +$189K 0.02% 993
2016
Q4 		$636K Buy
13,300
+9,800
+280% +$388K 0.01% 1263
2016
Q3 		$128K Buy
+3,500
New +$110K ﹤0.01% 2314
2016
Q2 		– Sell
-2,700
Closed -$109K – 3553
2016
Q1 		$109K Sell
2,700
-3,100
-53% -$126K ﹤0.01% 2525
2015
Q4 		$359K Sell
5,800
-23,000
-80% -$1.24M ﹤0.01% 2132
2015
Q3 		$1.16M Buy
28,800
+27,200
+1,700% +$1.41M 0.01% 1461
2015
Q2 		$92K Sell
1,600
-1,400
-47% -$89K ﹤0.01% 3105
2015
Q1 		$191K Sell
3,000
-4,100
-58% -$278K ﹤0.01% 2788
2014
Q4 		$438K Buy
7,100
+900
+15% +$44.4K ﹤0.01% 2436
2014
Q3 		$241K Sell
6,200
-22,700
-79% -$804K ﹤0.01% 3064
2014
Q2 		$996K Sell
28,900
-2,300
-7% -$72.4K ﹤0.01% 2136
2014
Q1 		$1.35M Sell
31,200
-36,900
-54% -$1.79M 0.01% 1818
2013
Q4 		$2.71M Buy
68,100
+23,000
+51% +$819K 0.01% 1295
2013
Q3 		$1.69M Buy
45,100
+14,800
+49% +$442K 0.01% 1506
2013
Q2 		$814K Buy
+30,300
New +$644K ﹤0.01% 2076

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Spot Trading's IONS Position: Q3 2017 in Review

Spot Trading sold out of Ionis Pharmaceuticals (IONS) in Q3 2017, closing a stake of 738 shares — an estimated $38.7K sold.

Spot Trading first reported a position in IONS in Q2 2013 and held it in 10 quarters. The position peaked at $766K in Q4 2013. 301 funds tracked by Wall St. Rank hold IONS as of Q3 2017.

  • Spot Trading reported no remaining Ionis Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 738 Ionis Pharmaceuticals shares in Q3 2017, an estimated $38.7K.
  • Spot Trading first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 10 quarters.
  • Spot Trading's Ionis Pharmaceuticals position peaked at $766K in Q4 2013.
  • 301 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.